144 results on '"Farah, Bruno"'
Search Results
2. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
3. Multicentre medicoeconomic evaluation of cardiac magnetic resonance imaging for predicting coronary artery disease in left ventricular dysfunction: The CAMAREC study design
4. Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock Initiative
5. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
6. Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial
7. Correction
8. French Registry on Acute ST-elevation and non−ST-elevation Myocardial Infarction 2015 (FAST-MI 2015). Design and baseline data
9. Percutaneous coronary intervention for left main coronary artery stenosis
10. TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement: The TIRATROP Study, A Randomized Controlled Trial
11. Cerebrovascular Events Post-Transcatheter Aortic Valve Replacement in a Large Cohort of Patients: A FRANCE-2 Registry Substudy
12. Percutaneous Left Atrial Appendage Closure Is a Reasonable Option for Patients With Atrial Fibrillation at High Risk for Cerebrovascular Events
13. Abstract 17319: Changes in Profile and Early Outcomes of STEMI Patients According to Use of Reperfusion Therapy: Data Over 20 Years From the FAST-MI Program 1995-2015
14. Compliance with guidelines in patients with ST-segment elevation myocardial infarction after implementation of specific guidelines for emergency care: Results of RESCA+31 registry
15. The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot Experience
16. UNEXPLAINED LEFT VENTRICULAR DYSFUNCTION: HOW IS CORONARY ANGIOGRAPHY USEFUL TODAY?
17. A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent: The PLATINUM (A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of up to Two De Novo Coronary Artery Lesions) Trial
18. The Utility of the SYNTAX Score II and SYNTAX Score 2020 for Identifying Patients with Three-Vessel Disease Eligible for Percutaneous Coronary Intervention in the Multivessel TALENT Trial: A Prospective Pilot Experience.
19. Extended Pseudo-Subarachnoid Hemorrhage Post-Percutaneous Coronary Intervention
20. Percutaneous coronary intervention for unprotected and protected left main stem disease
21. Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: Insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative
22. Management of stent loss and foreign body retrieval
23. Pronostic des syndromes coronariens aigus. Absence de différence en fonction du sexe
24. Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: Data from the FAST-MI program 1995-2015
25. Bioresorbable Scaffolds for Treatment of Coronary Bifurcation Lesions: Critical Appraisal and Future Perspectives
26. Late results of percutaneous mitral commissurotomy for calcific mitral stenosis
27. Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
28. THE COMPASS CRITERIA APPLIED TO A REAL LIFE POPULATION FROM THE FAST-MI 2005 AND 2010 REGISTRIES
29. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting
30. Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry
31. Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report
32. 0565: We are Charlie: emotional stress from “Charlie Hebdo attack” extensively relayed by media increases the risk of cardiac events
33. Transcatheter Aortic Valve Implantation With the Edwards SAPIEN Versus the Medtronic CoreValve Revalving System Devices A Multicenter Collaborative Study: The PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration)
34. A prospective, randomized evaluation of a novel everolimus-eluting coronary stent:the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial
35. O mal-estar da dependência na cultura neoliberal globalizada
36. FINAL FIVE-YEAR RESULTS OF THE PLATINUM RANDOMIZED TRIAL COMPARING PLATINUM CHROMIUM PROMUS ELEMENT AND COBALT CHROMIUM PROMUS/XIENCE V EVEROLIMUS-ELUTING STENTS IN WORKHORSE LESIONS
37. Churg-Strauss Syndrome Revealed by Acute Coronary Artery Disease: A Case Report*
38. Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system
39. Stent implantation in aorto-ostial lesions: long-term follow-up and predictors of outcome
40. O mal-estar da dependência na cultura neoliberal globalizada
41. The use of self-expanding stents in coronary bifurcations and beyond: a paradigm revisited
42. Impact of atherosclerotic disease progression on mid-term clinical outcome in diabetic patients in the drug-eluting stent era
43. Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcome
44. Impact of restenosis and disease progression on clinical outcome after multivessel stenting in diabetic patients
45. Clinical outcome after multivessel stenting in diabetic versus nondiabetic patients: Impact of restenosis and disease progression
46. Saphenous vein graft stenting using a novel filter device for distal protection
47. Coronary artery bypass graft or stent to treat unprotected left main coronary artery stenosis: Direct comparison of revascularization strategies
48. Does lesion location have an impact on long-term clinical outcome after unprotected left main coronary artery stenting?
49. Acute profound thrombocytopenia after use of eptifibatide for coronary stenting
50. Effects of Selective α 1 - and α 2 -Adrenergic Blockade on Coronary Flow Reserve After Coronary Stenting
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.